Ectopic expression of TrkC in PLC5/PRF/5 cells, which is weakly tumorigenic HCC cells, significantly increases the expression of mesenchymal markers (N-cadherin, fibronectin) but markedly reduces the expression of an epithelial marker such as E-cadherin. The gene discussed is CDH2; the disease is hepatocellular carcinoma.